Opportunity ID: 118333

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-71
Funding Opportunity Title: Biologically-derived Medicines on Demand
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Aug 30, 2011
Last Updated Date: Sep 09, 2011
Original Closing Date for Applications: Nov 15, 2011
Current Closing Date for Applications: Sep 09, 2011
Archive Date: Sep 12, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Defense Sciences Office
Description: The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs.
Link to Additional Information: DARPA-BAA-11-71
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

BAA Coordinator
Email:DARPA-BAA-11-71@darpa.mil

Version History

Version Modification Description Updated Date
The purpose of this Modification 1 to DARPA-BAA-11-71 Biologically-derived Medicines on Demand (Bio-MOD) is to cancel the BAA. Proposal Abstracts and Full Proposals are no longer being requested. Sep 09, 2011
Sep 09, 2011

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-71
Funding Opportunity Title: Biologically-derived Medicines on Demand
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Aug 30, 2011
Last Updated Date: Sep 09, 2011
Original Closing Date for Applications: Nov 15, 2011
Current Closing Date for Applications: Sep 09, 2011
Archive Date: Sep 12, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Defense Sciences Office
Description: The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs.
Link to Additional Information: DARPA-BAA-11-71
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

BAA Coordinator
Email:DARPA-BAA-11-71@darpa.mil

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-71
Funding Opportunity Title: Biologically-derived Medicines on Demand
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 09, 2011
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Nov 15, 2011
Archive Date: Dec 15, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Defense Sciences Office
Description: The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs.
Link to Additional Information: DARPA-BAA-11-71
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

BAA Coordinator
Email:DARPA-BAA-11-71@darpa.mil

Folder 118333 Full Announcement-1 -> darpa-baa-11-71.pdf

Packages

Agency Contact Information: BAA Coordinator
Email: DARPA-BAA-11-71@darpa.mil
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.910 PKG00075350 Aug 30, 2011 Sep 10, 2011 View

Package 1

Mandatory forms

118333 RR_SF424-1.1.pdf

Optional forms

118333 RR_FedNonFedBudget-1.1.pdf

118333 RR_FedNonFed_SubawardBudget-1.2.pdf

118333 RR_OtherProjectInfo-1.1.pdf

118333 RR_Budget-1.1.pdf

118333 RR_KeyPersonExpanded-1.1.pdf

118333 RR_PerformanceSite-1.1.pdf

118333 RR_SubawardBudget-1.2.pdf

2025-07-13T15:50:46-05:00

Share This Post, Choose Your Platform!

About the Author: